Skip to main content

Technology Enhancement Grant (TEG)

Maximum Award: 

Program Description

The Technology Enhancement Grant (TEG) Program provides non-repayable grant funding to North Carolina universities or other NC research institutions through their respective technology transfer or entrepreneurship partners. Under this program, awards of up to $75,000 are available to fund a commercially-focused research study to enhance the university’s licensing position for a commercially promising technology. The proposed project will ideally incorporate study endpoints designed to meet key milestones defined by potential licensees or industry-experienced technology development advisors.


Proposals to the TEG program must:

  • Be submitted by (1) a technology transfer officer (or other official with licensing authority), or (2) a representative of a qualified entrepreneurial development organization, working on behalf of a North Carolina university or non-profit research institution.
  • Pertain to a proprietary life sciences technology.
  • Demonstrate that protection of licensable intellectual property (IP) has been initiated (minimally, the filing of a provisional patent).
  • Attest that the IP rights are assigned to the applicant’s institution and have not been committed through license, option or letter-of-intent to license to any third-party at the time of application.
  • Demonstrate that an initial review of the technology and its commercial opportunity has been reviewed by an independent technology development professional, or that a dialog with an independent potential licensee of the technology has been initiated.

The Biotechnology Center determines compliance with these requirements at its sole discretion on a case-by-case basis.

Permitted Use of Funds

TEG funds are intended to support activities directly associated with the execution of a research project that is designed to achieve a significant technical milestone in the evolution of a technology from basic science to licensable commercial product or service. Examples of such projects include establishment of proof-of-concept, lead identification or optimization, target validation, prototype development, preliminary safety testing, etc.  Funding may be used to engage a non-academic contract research provider as needed. Please note that these funds may not be used to fund a basic science research study that is not directly tied to any commercial application or established licensing milestone. TEG funds may not be applied to expenses incurred prior to the date of award notification. The use of TEG funds for activities other than those approved by the Biotechnology Center is strictly prohibited unless prior written permission is obtained.

Application Procedures

Qualified applicants (as defined above) interested in applying for a TEG are invited to contact us as directed below to discuss the proposed project and the application procedures.

Pre-Proposal: Once eligibility and general fit for the program have been established, the applicant will be invited to submit a brief (2-page) pre-proposal describing the technology, its likely commercial application(s), IP and licensing status, licensing discussions to date, an overview of the proposed study, and how the study will directly impact the applicant’s ability to license the technology.

Full Proposal: Upon satisfactory review of the pre-proposal, the applicant will be invited to submit a full application. This application will expand upon each component described in the pre-proposal as well as provide a cover sheet, summary and detailed budget, and other supporting documentation as needed. The final proposal should be 10-15 pages in length.

Review and Approval: The Business and Technology Development team will thoroughly review the submitted proposal and will present competitive proposals to the Biotechnology Center’s President/CEO for final review and approval.

Application Deadlines: TEG submissions are accepted and approved on a rolling basis throughout the year.

Post Award Considerations

Fund distribution: TEG funds are distributed as reimbursements on an invoicing basis, requiring the submission of receipts to the Biotechnology Center’s Contracts & Grants Office.

Repayment: TEG awards are non-repayable grants made to the university or institutional awardee.

Progress reports:  Mid-term and final project reports are required which include a detailed update of progress against proposed milestones and time lines, as well as actual spending to date versus budget. The Biotechnology Center will actively monitor progress until the project is completed.

Recent TEG Awardees

FY 2012

FY 2013

FY 2014 

FY 2015

Duke University

NC Central University

UNC-Chapel Hill

Duke University

Duke University

UNC-Chapel Hill

NC State University

NC A&T State University

UNC-Chapel Hill

UNC-Chapel Hill

Other awardees include East Carolina University, UNC-Charlotte, UNC-Wilmington, and UNC-Greensboro.


Contact Dr. Rob Lindberg at (919) 549-8826 or with questions regarding this program or to schedule a preliminary meeting.

Download a printable version of this page